Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2011-5-23
pubmed:databankReference
pubmed:abstractText
The safety of intranasal live-attenuated influenza vaccine (LAIV) in immunocompromised children with cancer is unknown. The objective of this study was to describe the safety and immunogenicity of LAIV in mild to moderately immunocompromised children with cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1873-2518
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
31
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4110-5
pubmed:meshHeading
pubmed-meshheading:21496468-Administration, Intranasal, pubmed-meshheading:21496468-Adolescent, pubmed-meshheading:21496468-Antibodies, Viral, pubmed-meshheading:21496468-Child, pubmed-meshheading:21496468-Child, Preschool, pubmed-meshheading:21496468-Double-Blind Method, pubmed-meshheading:21496468-Female, pubmed-meshheading:21496468-Hemagglutination Inhibition Tests, pubmed-meshheading:21496468-Humans, pubmed-meshheading:21496468-Immunocompromised Host, pubmed-meshheading:21496468-Influenza, Human, pubmed-meshheading:21496468-Influenza Vaccines, pubmed-meshheading:21496468-Male, pubmed-meshheading:21496468-Nasal Mucosa, pubmed-meshheading:21496468-Neoplasms, pubmed-meshheading:21496468-Placebos, pubmed-meshheading:21496468-Vaccines, Attenuated, pubmed-meshheading:21496468-Virus Shedding
pubmed:year
2011
pubmed:articleTitle
Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
pubmed:affiliation
Vanderbilt University Medical Center, 1161 21st Ave South, Nashville, TN 37232, USA. natasha.halasa@vanderbilt.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study